Mercado global de genómica y proteómica de células individuales: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado de la proteómica y genómica de células individuales

El aumento de los gastos de I+D en el sector farmacéutico y biotecnológico y la financiación gubernamental para la proteómica son esenciales para impulsar el crecimiento del mercado. Existe una creciente necesidad de SCA (análisis de células individuales) en proteómica, genómica, transcriptómica y metabolómica. La creciente demanda de herramientas analíticas para la investigación innovadora y la financiación ha llevado a la introducción generalizada de equipos de alto rendimiento.

Data Bridge Market Research analiza que el mercado de genómica y proteómica de células individuales, que fue de USD 3.5 mil millones en 2022, aumentaría a USD 11.08 mil millones para 2030 y se espera que experimente una CAGR del 15,50% durante el período de pronóstico de 2023 a 2030. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología de pacientes, análisis de canalización, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de la genómica y proteómica de células individuales

Definición de mercado

La genómica unicelular es un método para examinar la heterogeneidad de las células e identificar nuevas características moleculares relacionadas con los resultados clínicos. Esta estrategia permite identificar la complejidad de la variedad celular en una muestra sin la pérdida de datos que se produce al analizar muestras de tejido multicelular o en masa.

Dinámica del mercado global de genómica y proteómica de células individuales

Conductores

• Aumentar la financiación para el desarrollo del mercado

Hay numerosas empresas que están recibiendo financiación para mejorar su mercado. Por ejemplo, Deepcell Inc., una empresa con sede en EE. UU., recibió una financiación de 73 millones de dólares para mejorar su plataforma de análisis de células individuales impulsada por IA y avanzar hacia la comercialización en 2022. Por lo tanto, los principales actores del mercado están considerando invertir en el desarrollo de soluciones para generar ingresos en los próximos años. Este factor conduce al crecimiento del mercado.

• Aumento de la prevalencia del cáncer

According to the American Cancer Society, cancer is the second most common cause of death in the U.S. As per the cancer statistics, in 2022, around 1.9 million new cancer cases are anticipated to occur in the U.S. This increasing incidence of cancer demands more and more studies and experiments, which further demands the use of SCA genomics and proteomics. Thus, this factor boosts market growth.

Opportunities

• Increasing Technological Advancements by Market Players

Several technologies, such as the development of next-generation sequencing for analyzing cellular expressions, mass spectrometry, and FISH (Fluorescence in situ hybridization), are greatly helping in the process of SCA. Furthermore, the market is witnessing the growing automation of machines and artificial intelligence for data analysis. Numerous software and computational methods have been developed and used because of their benefits, such as flexibility, scalability, and high success rates. For instance, there were more than 1000 single-cell RNA analysis tools in 2021. Thus, this factor boosts market growth.

• Increased Partnerships between Organizations and Market Players

There have been increasing partnerships between several organizations and market players, leading to the market's growth. For instance, Lifebit announced its partnership with Boehringer Ingelheim in 2022. The partnership will use the Cloud O.S. of Lifebit, the first federated platform for genomics, to build a data analytics infrastructure for Boehringer. Boehringer was also related to Lifebit's REAL platform in 2021 to increase the detection and tracking of disease outbreaks. Thus, this factor boosts market growth.

Restraints/Challenges

• High Cost of Proteomic Instruments

The high cost of proteomics instruments leads to market hindrances as they cannot be appointed by many underdeveloped nations' hospitals and research institutes. Also, a lot of maintenance is required to keep the consistency good. Thus, this factor impedes market growth.  

This single cell genomics and proteomics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the single cell genomics and proteomics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2021, the HIVETM scRNAseq Solution for single-cell isolation and analysis was launched by PerkinElmer, Inc. and Honeycomb Biotechnologies, Inc. This is a portable device used by the HIVE solution to capture, store, and prepare RNA-Seq libraries for several cell types, including fragile and labile cells such as granulocytes, nephrons, hepatocytes, and neurons.
• In 2021, CytoFlex SRT Benchtop Cell Sorter from Beckman Coulter Life Sciences was launched, which includes extended laser and color options for use in labs of all sizes. With the initiation of new technology, automating, streamlining, and stream maintenance became easy.

Global Single Cell Genomics and Proteomics Market Scope

The single cell genomics and proteomics market is segmented on the basis of single cell genomics process step, single cell genomics analytical technology, proteomics components, proteomics reagents, proteomics services & software, single cell genomics applications, proteomic application and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Single Cell Genomics Process Step

• Cell isolation
• Sample Preparation
• Genomics Analysis

 Single Cell Genomics Analytical Technology

• Tubing PCR
• Qpcr
• Microarray
• Next-Generation-Sequencing
• Other

 Proteomics Components

• Instruments
• Reagents
• Services

Proteomics Reagents

• Immunoassay Reagents
• Spectroscopy Reagents
• Chromatography Reagents
• Protein Microarray Reagents
• X-Ray Crystallography Reagents
• Electrophoresis Reagents
• Protein Fractionation Reagents

Proteomics Services & Software

• Core Proteomics Services
• Bioinformatics Software & Services

Single Cell Genomics Applications

• Genomic Variation
• Subpopulation Characterization
• Circulating Tumor Cells
• Cell Differentiation / Reprograming Method
• Others

Proteomic Application

• Drug Discovery
• Disease Diagnosis
• Other

End- Users

• Academic Institutes
• Biopharmaceutical Companies
• Clinical Research Institutes

Single Cell Genomics and Proteomics Market Regional Analysis/Insights

The single cell genomics and proteomics market is analyzed and market size insights and trends are provided by single cell genomics process step, single cell genomics analytical technology, proteomics components, proteomics reagents, proteomics services & software, single cell genomics applications, proteomic application and end-users as referenced above.

The countries covered in the single cell genomics and proteomics market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the single cell genomics and proteomics market due to multiple government funding programs, increasing awareness regarding personal healthcare and associated expenditure, high adoption of novel analytical tools and techniques, and the wide availability of trained personnel. Also, the U.S. is a major contributor to industry growth in the North American region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period because of the presence of national centers and local emerging economies offering such facilities. Furthermore, the major market players associated with this market are also enhancing the growth of the market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The single cell genomics and proteomics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for single cell genomics and proteomics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the single cell genomics and proteomics market. The data is available for historic period 2011-2021.

Competitive Landscape and Single Cell Genomics and Proteomics Market Share Analysis

El panorama competitivo del mercado de la genómica y la proteómica de células individuales proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y la variedad de productos, y el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de la genómica y la proteómica de células individuales.

Algunos de los principales actores que operan en el mercado de la genómica y proteómica de células individuales son:

• Thermo Fisher Scientific (Estados Unidos)
• QIAGEN (Países Bajos)
• Agilent Technologies, Inc. (Estados Unidos)
• Corporación McKesson (Estados Unidos)
• R1 RCM Inc., (Estados Unidos)
• Allscripts Healthcare, LLC, (Estados Unidos)
• Accenture, (Irlanda)
• Siemens, (Alemania)
• F. Hoffmann-La Roche Ltd. (Suiza)
• Laboratorios Bio-Rad, Inc. (Estados Unidos)
• BGI (China)
• BD (Estados Unidos)
• Danaher (Estados Unidos)
• Bruker (Estados Unidos)
• 10x Genomics (Estados Unidos)
• Corporación Luminex (Estados Unidos)
• Corporación Promega (Estados Unidos)

SKU-47743